The Memokath™ 028 procedure typically requires only local anesthesia. In most cases, preparation is the same as any endoscopy procedure. Your healthcare provider will inform you if any specific steps are necessary based on your individual needs.
Patients may experience some discomfort during the procedure, particularly when the stent and warm water are introduced. This sensation is usually not described as pain. To reduce discomfort, a local anesthetic gel is often used as a local anesthesia. Your healthcare provider will decide the most suitable approach for your individual needs.
Most patients do not experience significant pain after the procedure. However, some may notice mild irritation or traces of blood in the urine. Your healthcare provider will let you know what symptoms are normal and when to seek follow-up advice if needed.
Most patients can return to their normal daily activities shortly after the procedure. A brief rest period is usually recommended. Your healthcare provider will advise you on what activity level is appropriate based on your individual condition and the type of procedure performed.
Because the stent is placed internally through the urinary tract, the procedure generally does not cause any external wounds. Some patients may notice blood in the urine after the procedure. Your healthcare provider will explain what to expect and advise you if any care is needed
Patients are advised to avoid vigorous physical activity for up to two weeks after the insertion of the Memokath™ 028 prostate stent. In case of emergency, healthcare professionals should avoid using urinary catheters larger than 12 CH. Patients should keep the patient card with them at all times.
The Memokath™ 028 prostate stent is made from a biocompatible nickel–titanium alloy (NiTi), a material commonly used in medical devices. The stent is designed to minimize nickel ion release because the surface does not contain nickel
A typical follow-up schedule after Memokath™ 028 prostate stent insertion includes a check-in the day after the procedure – usually by phone – to confirm proper urinary drainage. A subsequent follow up – can also be done by phone – to confirm the urinary drainage and absence of any lower urinary tract symptoms. Additional follow-up is recommended after one month, and again at six-month intervals to monitor stent function and patient well-being.
To help reduce the risk of stent encrustation following Memokath™ 028 prostate stent insertion, patients are encouraged to maintain adequate daily fluid intake or keeping the fluid balance on positive side. Proper hydration supports healthy urinary flow, which may help limit the accumulation of mineral deposits on the stent surface. If encrustation occurs, the Memokath™ 028 prostate stent is engineered for non-surgical removal or replacement using minimally invasive techniques.
To help minimize the risk of stent migration when using Memokath™ 028 prostate stent, dilation is generally not a part of the procedure. If there is uncertainty between two stent lengths, selecting the longer stent is typically recommended to support optimal positioning and stability
The insertion technique for Memokath™ stents is simple, and many healthcare professionals become familiar with it after the first procedure. The procedure step by step is included in the Instructions For Use with every stent package. Our product specialists will be present during the initial cases to support you until you feel confident performing the insertion independently.
For Memokath™ 044, local anesthesia is commonly sufficient. If visual internal urethrotomy (VIU) or dilatation is required, general or spinal anesthesia may be used. Your healthcare provider will guide you based on the planned procedure. Other preparations like giving antibiotics are decided by healthcare providers if needed
Most patients experience little to no pain during the procedure. Local anesthesia is typically used to minimize any discomfort. In cases where general or spinal anesthesia is applied, patients are unlikely to feel anything during the procedure. Your healthcare provider will discuss the appropriate anesthesia method with you in advance and ensure it aligns with your medical needs and comfort
Following insertion of the Memokath™ 044 stent, most patients experience little to no pain. Some mild irritation or temporary blood in the urine may occur following the procedure. Your healthcare provider will advise you on what to expect and when to seek follow-up if needed.
Most patients can return to their normal daily activities shortly after the procedure. A brief rest period is usually recommended. Your healthcare provider will advise you on what activity level is appropriate based on your individual condition and the type of procedure performed.
Because the stent is placed internally through the urinary tract, the procedure generally does not cause any external wounds. Some patients may notice blood in the urine after the procedure. Your healthcare provider will explain what to expect and advise you if any care is needed
Patients are advised to avoid vigorous physical activity for up to two weeks after the insertion of the Memokath™ 044 urethral stent. In case of emergency, do not use a catheter exceeding 12 CH.
The Memokath™ 044 urethra stent is made from a biocompatible nickel–titanium alloy (NiTi), a material commonly used in medical devices. The stent is designed to minimize nickel ion release because the surface does not contain nickel
A typical follow-up schedule after Memokath™ 044 urethra stent insertion includes a check-in the day after the procedure – usually by phone – to confirm proper urinary drainage. A subsequent follow up – can also be done by phone – to confirm the urinary drainage and absence of any lower urinary tract symptoms. Additional follow-up is recommended after one month, and again at six-month intervals to monitor stent function and patient well-being. Depending on the patient’s medical history, imaging techniques such as renography or x-ray are commonly used to assess stent function and urinary drainage.
To help reduce the risk of stent encrustation following Memokath™ 044 urethra stent insertion, patients are encouraged to maintain adequate daily fluid intake or keeping the fluid balance on positive side. Proper hydration supports healthy urinary flow, which may help limit the accumulation of mineral deposits on the stent surface. If encrustation occurs, the Memokath™ 044 urethra prostate stent is engineered for non-surgical removal or replacement using minimally invasive techniques.
When placing the Memokath™ 044 urethral stent, balloon dilatation should not exceed 26 CH, as larger sizes may increase the risk of migration. Ask the patient to carry the patient card with him at all times
The insertion technique for Memokath™ stents is simple, and many healthcare professionals become familiar with it after the first procedure. Our product specialists will be present during the initial cases to support you until you feel confident performing the insertion independently. The procedure step by step is included in the Instructions For Use with every stent package.
For Memokath™ 045, local anesthesia is commonly sufficient. If visual internal urethrotomy (VIU) or dilatation is required, general or spinal anesthesia may be used. Other preparations like giving protective antibiotic is decided by healthcare providers. Your healthcare provider will guide you based on the planned procedure.
Most patients experience little to no pain during the procedure. Local anesthesia is typically used to minimize any discomfort. In cases where general or spinal anesthesia is applied, patients are unlikely to feel anything during the procedure. Your healthcare provider will discuss the appropriate anesthesia method with you in advance and ensure it aligns with your medical needs and comfort
Following insertion of the Memokath™ 045 stent, most patients experience little to no pain. Some mild irritation or temporary blood in the urine may occur following the procedure. Your healthcare provider will advise you on what to expect and when to seek follow-up if needed.
Most patients can return to their normal daily activities shortly after the procedure. A brief rest period is usually recommended. Your healthcare provider will advise you on what activity level is appropriate based on your individual condition and the type of procedure performed.
Because the stent is placed internally through the urinary tract, the procedure generally does not cause any external wounds. Some patients may notice blood in the urine after the procedure. Your healthcare provider will explain what to expect and advise you if any care is needed
Patients are advised to avoid vigorous physical activity for up to two weeks after the insertion of the Memokath™ 045 bladder neck stent. In case of emergency, do not use a catheter exceeding 12 CH.
The Memokath™ 045 bladder neck stent is made from a biocompatible nickel–titanium alloy (NiTi), a material commonly used in medical devices. The stent is designed to minimize nickel ion release because the surface does not contain nickel
A typical follow-up schedule after Memokath™ 045 bladder neck stent insertion includes a check-in the day after the procedure – usually by phone – to confirm proper urinary drainage. A subsequent follow up – can also be done by phone – to confirm the urinary drainage and absence of any lower urinary tract symptoms. Additional follow-up is recommended after one month, and again at six-month intervals to monitor stent function and patient well-being. Depending on the patient’s medical history, imaging techniques such as renography or x-ray are commonly used to assess stent function and urinary drainage.
To help reduce the risk of stent encrustation following Memokath™ 045 bladder neck stent insertion, patients are encouraged to maintain adequate daily fluid intake or keeping the fluid balance on positive side. Proper hydration supports healthy urinary flow, which may help limit the accumulation of mineral deposits on the stent surface. If encrustation occurs, the Memokath™ 045 bladder neck stent is engineered for non-surgical removal or replacement using minimally invasive techniques.
When placing the Memokath™ 045 bladder neck stent, balloon dilatation should not exceed 26 CH, as larger sizes may increase the risk of migration.
The insertion technique for Memokath™ stents is simple, and many healthcare professionals become familiar with it after the first procedure. Our product specialists will be present during the initial cases to support you until you feel confident performing the insertion independently. The procedure step by step is included in the Instructions For Use with every stent package.
For Memokath™ 051, local anesthesia can be sufficient. If visual internal urethrotomy (VIU) or dilatation is required, general or spinal anesthesia may be used. Other preparations like giving antibiotics for protection are decided by your healthcare providers. Your healthcare provider will guide you based on the planned procedure.
Most patients experience little to no pain during the procedure. Local anesthesia is typically used to minimize any discomfort. In cases where general or spinal anesthesia is applied, patients are unlikely to feel anything during the procedure. Your healthcare provider will discuss the appropriate anesthesia method with you in advance and ensure it aligns with your medical needs and comfort.
Following insertion of the Memokath™ 051 stent, most patients experience little to no pain. Some mild irritation or temporary blood in the urine may occur following the procedure. Your healthcare provider will advise you on what to expect and when to seek follow-up if needed.
Most patients can return to their normal daily activities shortly after the procedure. A brief rest period is usually recommended. Your healthcare provider will advise you on what activity level is appropriate based on your individual condition and the type of procedure performed.
Retrograde insertion through the urinary tract typically does not result in any external wounds. If antegrade insertion is performed, a small skin incision may be made. Your healthcare provider will guide you on how to care for the site after the procedure.
Patients are advised to avoid vigorous physical activity for up to two weeks after the insertion of the Memokath™ 051 ureteral stent.
The Memokath™ 051 ureter stent is made from a biocompatible nickel–titanium alloy (NiTi), a material commonly used in medical devices. The stent is designed to minimize nickel ion release because the surface does not contain nickel
A typical follow-up schedule after Memokath™ 051 ureteral stent insertion includes a check-in the day after the procedure – usually by phone – to confirm proper urinary drainage. A subsequent follow up – can also be done by phone – to confirm the urinary drainage and absence of any lower urinary tract symptoms. Additional follow-up is recommended after one month, and again at six-month intervals to monitor stent function and patient well-being. Depending on the patient’s medical history, imaging techniques such as renography or x-ray are commonly used to assess stent function and urinary drainage.
To help reduce the risk of stent encrustation following Memokath™ 051 ureteral stent insertion, patients are encouraged to maintain adequate daily fluid intake or more. Proper hydration supports healthy urinary flow or keeping the patient on positive fluid balance, which may help limit the accumulation of mineral deposits on the stent surface. If encrustation occurs, the Memokath™ 051 ureteral stent is engineered for non-surgical removal or replacement using minimally invasive techniques.
In PUJ (pelvi-ureteric junction) cases, a higher risk of stent migration will be expected. If balloon dilatation is necessary during insertion of the Memokath™ 051 ureteral stent, it is recommended not to exceed 14 CH
The insertion technique for Memokath™ stents is simple, and many healthcare professionals become familiar with it after the first procedure. Our product specialists will be present during the initial cases to support you until you feel confident performing the insertion independently. The procedure step by step is included in the Instructions For Use with every stent package.